School of Medicine
Showing 1-100 of 368 Results
-
Carla Abdelnour
Postdoctoral Scholar, Neurology and Neurological Sciences
BioOriginally from Caracas, Venezuela, Dr. Carla Abdelnour received her medical degree at the Central University of Venezuela, and then completed her neurology residency training at the University Hospital Príncipe de Asturias in Madrid, Spain. She conducted her doctorate in Medicine at the Autonomous University of Barcelona working with Drs. Dag Aarsland, Javier Pagonabarraga and Jaime Kulisevsky. Her thesis focused on the influence of Alzheimer´s disease copathology in atrophy patterns, longitudinal cognitive decline, and heterogeneity of patients with dementia with Lewy bodies.
Carla´s main interest is the study of neurodegenerative diseases, especially Lewy body disease. Her plan is to investigate the impact of different comorbidities in the clinical presentation, cognitive profile, and disease progression of Lewy body disease. Additionally, she wants to study the biological underpinnings of prodromal Lewy body disease to identify potential biomarkers for diagnosis and prognosis. -
Gregory W. Albers, MD
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
On Partial Leave from 04/01/2022 To 11/30/2022Current Research and Scholarly InterestsOur group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.
-
Katrin Andreasson
Professor of Neurology
Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.
-
Meredith Barad, MD
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor, Neurology & Neurological SciencesCurrent Research and Scholarly InterestsMy current research interests involve novel treatment paradigms for challenging pain problems such as orofacial pain, trigeminal neuralgia and low pressure headaches. I am also interested in migraine and trigeminal autonomic cephalgias and their intersection with chronic pain.
-
Fiona Baumer
Assistant Professor of Neurology and of Pediatrics
Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy
-
Michael Eddy F Belloy
Instructor, Neurology & Neurological Sciences
Postdoctoral Scholar, Neurology and Neurological SciencesBioMy broad scientific goal is to investigate neurological disorders with the aim of identifying novel mechanisms that improve understanding of disease pathophysiology and that could lead to novel drug development. I pursue this goal by investigating the genetic risk factors of the respective disease under question, studying how they contribute to disruptions of brain function measured by in vivo imaging techniques, and how they correlate with the presentation of disease-sensitive biomarkers. Within this broader scope, my primary interest is to focus specifically on Alzheimer's disease, elucidating the genetic, molecular, and clinical spectrum of the disease, and hopefully, eventually, contributing to the path towards a cure.
I am a highly interdisciplinary scientist with experience in programming (using various scripting languages), advanced data analyses methods, neuroimaging, and studies of preclinical mouse models of Alzheimer’s disease. I also have a long-standing interest in brain function and network dynamics in both health and disease. More recently, I have further gained experience into the clinical aspects, imaging approaches, and genetics of Alzheimer’s disease. Altogether, this translates into my current research strategy in which I investigate large-scale multimodal datasets that contain information on genetics, clinical outcome measures, structural and functional brain properties, and other biomarker data.
I am currently a third-year post-doc at Stanford university, under the lead of Dr. Michael D Greicius. My main aims in this lab are to identify genetic factors that may be causative to Alzheimer's disease. Specifically, I aim to uncover genetic risk factors that interact with the Apolipoprotein E (APOE) gene to alter risk for Alzheimer’s disease. Further, I seek to identify how these genetic interactions with APOE differ by sex, age, and ethnicity. I believe this will allow the identification of novel genes relevant to Alzheimer's disease and contribute to advancing personalized genetic medicine.
During my PhD, supervised by Dr. Marleen Verhoye, Dr. Shella Keilholz and Dr. Georgios A Keliris, I worked on developing dynamic resting state functional (rsf)MRI in mice, which lead to the first observation of mouse Quasi-Periodic patterns, and related applications for Alzheimer's disease research in rodents. I still have an ongoing interest in dynamic rsfMRI research. -
Sumana Bhowmick
Postdoctoral Scholar, Neurology and Neurological Sciences
BioMy main research interests focus on isolation and characterizing novel compounds and producing them with sufficient purity to be tested in biological systems followed by target discovery the use of '-omics' technologies.
My aim is to get associated with a challenging position within an organization wherein I can use my skills to the optimum level and at the same time get an opportunity to enhance my knowledge and pursue skills for further research work. -
Eran Blacher
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Blacher carried out his B.Sc studies in Life Sciences (2007-2010) and proceeded to Ph.D. in Neuroimmunology (2010-2015) under the Dean’s list honors direct Ph.D. program for outstanding students of Tel-Aviv University, Israel. His postdoctoral studies were carried out at the lab of Prof. Eran Elinav from the Immunology department at the Weizmann Institute of Science, Israel (2015-2018), where he studied the role of the Microbiome-gut-brain axis in the context of neurodegenerative diseases.
-
Helen Bronte-Stewart, MD, MS
John E. Cahill Family Professor, Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research focus is human motor control and brain pathophysiology in movement disorders. Our overall goal is to understand the role of the basal ganglia electrical activity in the pathogenesis of movement disorders. We have developed novel computerized technology to measure fine, limb and postural movement. With these we are measuring local field potentials in basal ganglia nuclei in patients with Parkinson's disease and dystonian and correlating brain signalling with motor behavior.
-
Martin Brown
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsWe seek to understand the mechanisms responsible for the resistance of cancers to treatment and to develop strategies to overcome these resistances. We are using molecular and cellular techniques and mouse models to potentiate the activity of radiation on tumors by inhibiting the bone marrow rescue of the tumor vasculature following therapy.
-
Axel Brunger
Professor of Molecular and Cellular Physiology, of Neurology, of Photon Science and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsOne of Axel Brunger's major goals is to decipher the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, combined with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.
-
Paul Buckmaster, DVM, PhD
Professor of Comparative Medicine and of Neurology
Current Research and Scholarly InterestsMechanisms of epilepsy, especially temporal lobe epilepsy.
-
Marion S. Buckwalter, MD, PhD
Professor of Neurology and of Neurosurgery
Current Research and Scholarly InterestsThe goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic and clinical research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how they affect short-term brain injury and long term outcomes like dementia and depression.
-
Marian (Mimi) Callanan
Affiliate, Neurology
BioMs. Callanan has many years experience as a Clinical Nurse Specialist in Epilepsy. She has been in this role at Stanford since the Center opened in 1990. She received her undergraduate degree at St Louis University and her graduate degree at the University of Pennsylvania. She is a past member of the Professional Advisory Board of the Epilepsy Foundation of America. She is a past President of the Epilepsy Society of San Francisco and was on the Board of Directors of the Epilepsy Foundation of Northern California. She is author of several publications pertaining to education of patients and families about epilepsy, and to the impact of epilepsy on life.
-
Felix Chang, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Felix Chang's clinical practice mainly involves intraoperative neurophysiologic monitoring (IONM) and the treatment of neurological disorders with botulinum toxin. He earned his medical degree at the University of Texas Southwestern Medical Center. He completed his neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston. He then went on to complete a fellowship in clinical neurophysiology with a focus in intraoperative neurophysiologic monitoring at Stanford.
-
Steven D. Chang, MD
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology
Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.
Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.
Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions. -
S. Charles Cho, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsClinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.
-
Mingyu Chung
Postdoctoral Scholar, Neurology and Neurological Sciences
Current Research and Scholarly InterestsRegulation of cell cycle and quiescence in tissue regeneration, homeostasis, and aging.
-
Robert Cowan, MD, FAAN
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain MedicineCurrent Research and Scholarly InterestsCurrent interest focus on patient education technology and patient/physician communication with a particular emphasis on tools which increase encounter efficiency and improve outcomes. Basic research focuses on mechanisms of action in Chronic Daily Headache, with a particular emphasis on New Daily Persistent Headache. Techniques include fMRI, biomarker investigation and evoked potentials. Clinical research includes clinical trials of novel treatments for episodic and chronic headache forms.
-
John W. Day, MD, PhD
Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology
Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
Jun Ding
Associate Professor of Neurosurgery and of Neurology
Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders
-
Les Dorfman, MD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsClinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.
-
Lauren Drag, PhD
Clinical Assistant Professor (Affiliated), Neurology
BioLauren Drag, PhD, is a Clinical Assistant Professor(Affiliated) in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She received her bachelor’s degree from Pomona College and a PhD in clinical psychology from the University of Arizona. Dr. Drag is board certified in Clinical Neuropsychology by the American Board of Professional Psychology.
She completed a clinical internship in neuropsychology at the VA Ann Arbor Medical Center and a two-year post-doctoral fellowship in neuropsychology at the University of Michigan Healthcare System. Prior to coming to Stanford, she was a researcher at the VA Palo Alto Medical Center and served as Director of the Neuropsychology Area of Emphasis at Palo Alto University. Dr. Drag’s research interests are in cognitive aging and traumatic brain injury. -
Dawn Duane
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor, Pediatrics - OperationsCurrent Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.
-
Shefali Dujari, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Dujari is a board-certified neurologist and fellowship-trained neurohospitalist, specializing in the care of acute neurologic disorders. She practices at both Stanford Hospital and Stanford ValleyCare. She completed her medical training at Boston University, internal medicine preliminary year at California Pacific Medical Center, neurology residency at Stanford University, and neurohospitalist fellowship at Stanford University. She serves as the Neurology Resident & Fellow Wellness & Mentoring Committee faculty lead, the associated program director of the Stanford Neurohospitalist Fellowship, and the physician lead of the ValleyCare Neuroscience Quality Committee. She has a special interest in medical education and quality improvement.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html -
Jeffrey Dunn, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Tina Duong MPT, PhD
Clinical Research Manager, Neurology
BioI am a research physical therapist with over 19 years of experience as a practicing clinician and most of it in neuromuscular clinical research. My doctoral studies focused on effects of contracture development on downstream musculoskeletal and biomechanical changes associated with changes in function.I hope to continue work in novel outcomes development with other neuromuscular diseases as well as pursue work on the benefits of rehabilitation and exercise as conjunctive therapies in neuromuscular disease.
Character is the driving force in my work and collaborations. The most important qualities I find in people are integrity, work ethic, humility, empathy, leadership, initiative and drive...I live by Ralph Waldo Emerson's Success poem..."to know even one life has breathed easier because you have lived. This is to have succeeded." I find it difficult at times to summarize ones own accomplishments or impact. So I would like to share a recommendation that was written about me in which I hope to refer back as my north star in both my personal and professional life.
"Dr Tina Duong is a world renown physiotherapist, master trainer, clinical investigator, scientific academician and most importantly an INCREDIBLE person. I had the privilege of working with her side by side during the development of a new therapy for spinal muscular atrophy. Her determination to help the scientific community, patients and carers is truly inspiring. Her knowledge and skills place her at the vanguard of clinical translation of data and meaningful patient outcomes. Her capabilities span everything from publications, meeting moderation, speaker events and clinical training. She has instinctive clinical intuition which allows her to support drug development and translation in both early stage and also during pivotal trial design, data interpretation and patient care and management. Her ethical and moral considerations of medicine and science means she is 100% focused on each individual to support them as best as possible and this is obvious from everyone who has worked or knows her. Her passion, energy and knowledge inspires people, teams and countries! Wherever Tina goes and whatever she embarks on now or in the future, the value she brings is like no one else and her impact is immediate. I personally look forward to the next opportunity to work with Tina as a brilliant scholar. She lives the ambition of: “The world is changed by your example, not by your opinion” -
Emmanuel During, MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
Clinical Associate Professor, Neurology & Neurological SciencesCurrent Research and Scholarly InterestsImproving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.
Controlling symptoms of RBD testing drugs rigorously.
Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome -
Faisal Fecto
Instructor, Neurology & Neurological Sciences
BioDr. Fecto is a board-certified neurologist and neuromuscular medicine specialist. Dr. Fecto completed his medical training at the Aga Khan University in Pakistan in 2005, where he was also junior faculty till 2006. Dr. Fecto completed his PhD in neuroscience at Northwestern University in 2012 during which he was supported by a University Fellowship and an NIH/NIA Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship. From 2012 to 2015 he completed his post-doctoral training in neurogenetics at Northwestern University as the Link Foundation Fellow. Dr. Fecto completed his neurology residency and chief residency at the University of Iowa Hospitals and Clinics as part of the clinical-neuroscientist and physician-scientist training programs. Dr. Fecto completed his fellowship in neuromuscular medicine at Stanford University in 2020.
Dr. Fecto has received several awards including the resident teaching award, resident team leader award, a resident lectureship by the Iowa Neurological Association, and a fellow scholarship by the American Academy of Neurology. Dr. Fecto is a well-published researcher and serves as an associate editor for the journal BMC Neurology. His research explores the pathogenic mechanisms that contribute to neuromuscular disorders such as amyotrophic lateral sclerosis and myotonic dystrophy. His research is supported by an NIH/NINDS R25 Research Education Grant. Dr. Fecto is a member of Alpha Omega Alpha Honor Medical Society, Sigma Xi Scientific Research Honor Society, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Society for Neuroscience, American Association for the Advancement of Science, and the American Medical Association. -
Anna Finley Caulfield, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.
-
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.
-
Robert Fisher, MD, PhD
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.
-
Nicole Francisco
Human Resources Administrator 1, Neurology
BioPronouns: she/her/hers
-
Paul George, MD, PhD
Assistant Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.
BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Carl Gold
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Gold is a board-certified general neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold has a particular clinical interest in the inpatient diagnosis of uncommon or rare neurological disorders. He directs quality improvement for the department of Neurology and is actively involved in projects to improve the experience of patients with neurological conditions at Stanford. His primary research interest focuses on enhancing the communication skills of neurology residents and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html
Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html
Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html -
Olga Fedin Goldberg
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.
-
Neelam Goyal, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Goyal specializes in the diagnosis, management, and electrophysiological testing of neuromuscular disorder (including SFEMG), with expertise in immune-mediated disorders (myositis, myasthenia gravis, CIDP, and vasculitis) and ALS. Her research interest include monitoring and managing toxicity of immunosuppressive agents. She is co-director of the MDA clinic, and provides botulinum toxin for treatment of sialorrhea for ALS patients.
-
Maxwell Greene, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Greene is a board-certified, fellowship-trained neurologist. He is also a Clinical Assistant Professor of Neurology at Stanford University School of Medicine.
Dr. Greene provides clinical care for adult patients with disorders of the muscles and peripheral nerves that cause weakness and numbness. He specializes in diagnosing and treating neuromuscular diseases that include amyotrophic lateral sclerosis (ALS), all types of muscular dystrophy, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Charcot-Marie-Tooth (CMT). For CIDP and CMT, Stanford is one of the few centers of excellence in the country.
A significant part of Dr. Greene’s practice involves investigational work, where he seeks to determine the cause of a patient’s symptoms. In addition to performing the full range of diagnostic tests including interpreting biopsy procedures, he has special qualifications in electrodiagnosis and the use of electromyography and nerve conduction studies.
Treatments offered by Dr. Greene cover the complete spectrum of options, with an emphasis on immune therapies for certain conditions. For CIDP and myasthenia gravis, he administers immune globulin, steroids, plasmapheresis, and rituximab. To help manage symptoms of CMT and support areas of the body weakened by this disease, he can recommend physical therapy, occupational therapy, and foot, ankle, and knee orthotics.
For the treatment of ALS and muscular dystrophy, Dr. Greene leads a multidisciplinary team offering physical and occupational therapy, pulmonary expertise, speech and swallow expertise, nutrition counseling, social services, and specialized nursing, and works together with genetic counseling. All team members collaborate closely to ensure patients receive the care and comfort needed to meet their emotional as well as physical needs.
As part of his commitment to advancing patients’ treatment options, Dr. Greene conducts clinical research. Among his current interests are
innovative new therapies for ALS and other nerve and muscular disorders. This is an exciting time in the field of neuromuscular medicine, with real potential for treatment breakthroughs for the first time in decades. Exploring these new directions enables Dr. Greene to offer Stanford patients access to options that may not be available anywhere else.
To highlight new advances for his peers, Dr. Greene has made national and regional presentations at conferences including the American Academy of Neurology meeting. Topics include the results of a study supported in part by the National Institutes of Health: paraneoplastic antibodies as markers of Hodgkin’s disease. JAMA Neurology published Dr. Greene’s article on this research.
Dr. Greene’s achievements have earned recognition from the American Academy of Neurology and other organizations. He is also the recipient of a travel award from the American Neurological Association and a grant from the NIH National Institute of Neurological Disorders and Stroke.
A member of the American Academy of Neurology, Dr. Greene is also an active member of the Western ALS Consortium and Northeastern ALS Consortium. -
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Medical Director of the Stanford Center for Memory Disorders and Principal Investigator of the Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort, Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
